The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Epithelial Myosin Light Chain Kinase Activation Induces Mucosal Interleukin-13 Expression to Alter Tight Junction Ion Selectivity
Open accessAbstract
Intestinal barrier function is reduced in inflammatory bowel disease (IBD). Tumor necrosis factor (TNF) and interleukin (IL)-13, which are up-regulated in IBD, induce barrier defects that are associated with myosin light chain kinase (MLCK) activation and increased claudin-2 expression, respectively, in cultured intestinal epithelial monolayers. Here we report that these independent signaling pathways have distinct effects on tight junction barrier properties and interact in vivo. MLCK activation alters size selectivity to enhance paracellular flux of uncharged macromolecules without affecting charge selectivity and can be rapidly reversed by MLCK inhibition. In contrast, IL-13-dependent claudin-2 expression increases paracellular cation flux in vitro and in vivo without altering tight junction size selectivity but is unaffected by MLCK inhibition in vitro. In vivo, MLCK activation increases paracellular flux of uncharged macromolecules and also triggers IL-13 expression, claudin-2 synthesis, and increased paracellular cation flux. We conclude that reversible, MLCK-dependent permeability increases cause mucosal immune activation that, in turn, feeds back on the tight junction to establish long-lasting barrier defects. Interactions between these otherwise distinct tight junction regulatory pathways may contribute to IBD pathogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis
Rutgeerts, P., Sandborn, W. J., Feagan, B. G., Reinisch, W., Olson, A., Johanns, J., Travers, S., Rachmilewitz, D., Hanauer, S. B., Lichtenstein, G. R., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050516 · Cited by 3,902
HELLER, F., FLORIAN, P., BOJARSKI, C., RICHTER, J., CHRIST, M., HILLENBRAND, B., MANKERTZ, J., GITTER, A., BURGEL, N., & FROMM, M. (2005) · Gastroenterology · doi:10.1016/j.gastro.2005.05.002 · Cited by 1,230
Järnerot, G., Hertervig, E., Friis-Liby, I., Blomquist, L., Karlén, P., Grännö, C., Vilien, M., Ström, M., Danielsson, Å., Verbaan, H., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.03.003 · Cited by 1,089
Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2)
van Dullemen, H. M., van Deventer, S. J. H., Hommes, D. W., Bijl, H. A., Jansen, J., Tytgat, G. N. J., & Woody, J. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90277-5 · Cited by 1,084
Proinflammatory Cytokines Disrupt Epithelial Barrier Function by Apoptosis-Independent Mechanisms
Bruewer, M., Luegering, A., Kucharzik, T., Parkos, C. A., Madara, J. L., Hopkins, A. M., & Nusrat, A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.11.6164 · Cited by 902
Fichtner-Feigl, S., Strober, W., Kawakami, K., Puri, R. K., & Kitani, A. (2006) · Nature Medicine · doi:10.1038/nm1332 · Cited by 889
Claudin-2 expression induces cation-selective channels in tight junctions of epithelial cells
Amasheh, S., Meiri, N., Gitter, A. H., Schöneberg, T., Mankertz, J., Schulzke, J. D., & Fromm, M. (2002) · Journal of Cell Science · doi:10.1242/jcs.00165 · Cited by 812
Fuss, I. J., Heller, F., Boirivant, M., Leon, F., Yoshida, M., Fichtner-Feigl, S., Yang, Z., Exley, M., Kitani, A., Blumberg, R. S., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19836 · Cited by 797
HOLLANDER, D., VADHEIM, C. M., BRETTHOLZ, E., PETERSEN, G. M., DELAHUNTY, T., & ROTTER, J. I. (1986) · Annals of Internal Medicine · doi:10.7326/0003-4819-105-6-883 · Cited by 760
Furuse, M., Furuse, K., Sasaki, H., & Tsukita, S. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.153.2.263 · Cited by 719
Cited by
Baumgart, D. C., & Sandborn, W. J. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60026-9 · Cited by 2,154
Claudins and the Modulation of Tight Junction Permeability
Günzel, D., & Yu, A. S. L. (2013) · Physiological Reviews · doi:10.1152/physrev.00019.2012 · Cited by 1,456
Regulation of intestinal epithelial permeability by tight junctions
Suzuki, T. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1070-x · Cited by 1,343
The intestinal epithelial barrier: a therapeutic target?
Odenwald, M. A., & Turner, J. R. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.169 · Cited by 1,288
Self-citationTight Junction Pore and Leak Pathways: A Dynamic Duo
Shen, L., Weber, C. R., Raleigh, D. R., Yu, D., & Turner, J. R. (2011) · Annual Review of Physiology · doi:10.1146/annurev-physiol-012110-142150 · Cited by 872
Self-citationIntestinal Barrier Dysfunction, LPS Translocation, and Disease Development
Ghosh, S. S., Wang, J., Yannie, P. J., & Ghosh, S. (2020) · Journal of the Endocrine Society · doi:10.1210/jendso/bvz039 · Cited by 759
Cell Biology of Tight Junction Barrier Regulation and Mucosal Disease
Buckley, A., & Turner, J. R. (2018) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a029314 · Cited by 720
Self-citationExperimental Models of Inflammatory Bowel Diseases
Kiesler, P., Fuss, I. J., & Strober, W. (2015) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2015.01.006 · Cited by 713
Paracellular permeability and tight junction regulation in gut health and disease
Horowitz, A., Chanez-Paredes, S. D., Haest, X., & Turner, J. R. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00766-3 · Cited by 687
Self-citationLuissint, A.-C., Parkos, C. A., & Nusrat, A. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.07.008 · Cited by 555
Predicted expansion of the claudin multigene family
Mineta, K., Yamamoto, Y., Yamazaki, Y., Tanaka, H., Tada, Y., Saito, K., Tamura, A., Igarashi, M., Endo, T., Takeuchi, K., et al. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.01.028 · Cited by 531
Suzuki, T., Yoshinaga, N., & Tanabe, S. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.238147 · Cited by 525
Landy, J., Ronde, E., English, N., Clark, S. K., Hart, A. L., Knight, S. C., Ciclitira, P. J., & Al-Hassi, H. O. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i11.3117 · Cited by 507
Lundquist, P., & Artursson, P. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.07.007 · Cited by 483
Marchiando, A. M., Shen, L., Graham, W. V., Weber, C. R., Schwarz, B. T., Austin, J. R., Raleigh, D. R., Guan, Y., Watson, A. J. M., Montrose, M. H., et al. (2010) · Journal of Cell Biology · doi:10.1083/jcb.200902153 · Cited by 477
Self-citationIntestinal epithelial claudins: expression and regulation in homeostasis and inflammation
Garcia‐Hernandez, V., Quiros, M., & Nusrat, A. (2017) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13360 · Cited by 445
Tight Junction Proteins and Signaling Pathways in Cancer and Inflammation: A Functional Crosstalk
Bhat, A. A., Uppada, S., Achkar, I. W., Hashem, S., Yadav, S. K., Shanmugakonar, M., Al-Naemi, H. A., Haris, M., & Uddin, S. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2018.01942 · Cited by 400
Su, L., Nalle, S. C., Shen, L., Turner, E. S., Singh, G., Breskin, L. A., Khramtsova, E. A., Khramtsova, G., Tsai, P., Fu, Y., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.04.011 · Cited by 397
Self-citationIntestinal Permeability Defects: Is It Time to Treat?
Odenwald, M. A., & Turner, J. R. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.07.001 · Cited by 366
“Notably, claudin-2 expression and MLCK activity are both increased in active IBD,(22,26) suggesting that both pathways are involved in disease-associated barrier loss.(15,17) 576”
Self-citationMyosin light chain kinase: pulling the strings of epithelial tight junction function
Cunningham, K. E., & Turner, J. R. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06526.x · Cited by 345
Self-citationIntestinal Permeability, Inflammation and the Role of Nutrients
Farré, R., Fiorani, M., Abdu Rahiman, S., & Matteoli, G. (2020) · Nutrients · doi:10.3390/nu12041185 · Cited by 290
Claudin-2 as a mediator of leaky gut barrier during intestinal inflammation
Luettig, J., Rosenthal, R., Barmeyer, C., & Schulzke, J. (2015) · Tissue Barriers · doi:10.4161/21688370.2014.977176 · Cited by 277
Determinants of colonic barrier function in inflammatory bowel disease and potential therapeutics
Hering, N. A., Fromm, M., & Schulzke, J. (2012) · The Journal of Physiology · doi:10.1113/jphysiol.2011.224568 · Cited by 275
The mucosal barrier at a glance
France, M. M., & Turner, J. R. (2017) · Journal of Cell Science · doi:10.1242/jcs.193482 · Cited by 267
Self-citationIL-22 Upregulates Epithelial Claudin-2 to Drive Diarrhea and Enteric Pathogen Clearance
Tsai, P.-Y., Zhang, B., He, W.-Q., Zha, J.-M., Odenwald, M. A., Singh, G., Tamura, A., Shen, L., Sailer, A., Yeruva, S., et al. (2017) · Cell Host & Microbe · doi:10.1016/j.chom.2017.05.009 · Cited by 266
Self-citationClaudins in intestines: Distribution and functional significance in health and diseases
Lu, Z., Ding, L., Lu, Q., & Chen, Y.-H. (2013) · Tissue Barriers · doi:10.4161/tisb.24978 · Cited by 266
Fritscher-Ravens, A., Pflaum, T., Mösinger, M., Ruchay, Z., Röcken, C., Milla, P. J., Das, M., Böttner, M., Wedel, T., & Schuppan, D. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.03.046 · Cited by 248
Frantz, A. L., Rogier, E. W., Weber, C. R., Shen, L., Cohen, D. A., Fenton, L. A., Bruno, M. E. C., & Kaetzel, C. S. (2012) · Mucosal Immunology · doi:10.1038/mi.2012.23 · Cited by 230
Self-citationCRF induces intestinal epithelial barrier injury via the release of mast cell proteases and TNF-α
Overman, E. L., Rivier, J. E., & Moeser, A. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039935 · Cited by 207
The role of molecular remodeling in differential regulation of tight junction permeability
Turner, J. R., Buschmann, M. M., Romero-Calvo, I., Sailer, A., & Shen, L. (2014) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2014.09.022 · Cited by 200
“Thus, a major component of TNF-induced increases in paracellular permeability is due to enhanced flux across the nonrestrictive class of pores [20, 23-25].”
BackgroundSelf-citationIntestinal Barrier Dysfunction in Irritable Bowel Syndrome: A Systematic Review
Hanning, N., Edwinson, A. L., Ceuleers, H., Peters, S. A., De Man, J. G., Hassett, L. C., De Winter, B. Y., & Grover, M. (2021) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756284821993586 · Cited by 197
Buschmann, M. M., Shen, L., Rajapakse, H., Raleigh, D. R., Wang, Y., Wang, Y., Lingaraju, A., Zha, J., Abbott, E., McAuley, E. M., et al. (2013) · Molecular Biology of the Cell · doi:10.1091/mbc.e12-09-0688 · Cited by 192
“IL-13–induced or transgenic claudin-2 expression (Van Itallie et al., 2008; Weber et al., 2010), and a low-capacity, charge- and size-nonselective leak pathway that requires ZO-1 for maintenance and can be regulated by TNF via MLCK- and caveolin-1–dependent occludin endocytosis.”
BackgroundMethodInfluentialSelf-citationTight junctions as targets and effectors of mucosal immune homeostasis
Zuo, L., Kuo, W.-T., & Turner, J. R. (2020) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2020.04.001 · Cited by 191
Self-citationSerine proteases as luminal mediators of intestinal barrier dysfunction and symptom severity in IBS
Edogawa, S., Edwinson, A. L., Peters, S. A., Chikkamenahalli, L. L., Sundt, W., Graves, S., Gurunathan, S. V., Breen-Lyles, M., Johnson, S., Dyer, R., et al. (2020) · Gut · doi:10.1136/gutjnl-2018-317416 · Cited by 101
Al-Sadi, R., Engers, J., Haque, M., King, S., Al-Omari, D., & Ma, T. Y. (2021) · PLOS ONE · doi:10.1371/journal.pone.0249544 · Cited by 93
Keita, Å. V., Carlsson, A. H., Cigéhn, M., Ericson, A. ‐., McKay, D. M., & Söderholm, J. D. (2013) · Neurogastroenterology & Motility · doi:10.1111/nmo.12127 · Cited by 53
Metadata
- Authors
- Weber, C. R., Raleigh, D. R., Su, L., Shen, L., Sullivan, E. A., Wang, Y., & Turner, J. R.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2010-04
- Volume
- 285
- Issue
- 16
- Pages
- 12037-12046
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2013657751
- Cited by
- 298
- References
- 50
- FWCI
- 11.08
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.